A methodology study to develop and validate a screener for hypoactive sexual desire disorder in postmenopausal women

被引:42
作者
Leiblum, S
Symonds, T
Moore, J
Soni, P
Steinberg, S
Sisson, M
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Psychiat, Ctr Sexual & Relationship Hlth, Piscataway, NJ 08854 USA
[2] Pfizer Ltd, World Wide Outcomes Res, Sandwich CT13 9NJ, Kent, England
[3] Pfizer Inc, Global Res & Dev, New London, CT USA
关键词
hypoactive sexual desire disorder; diagnostic testing; history; physical examination;
D O I
10.1111/j.1743-6109.2006.00247.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Introduction. Current methods for diagnosing hypoactive sexual desire disorder (HSDD) can be complicated and time-consuming. A previous Study reported validity and reliability of a structured diagnostic method created for clinical trials that can be performed in approximately 1 hour. Methods. A more succinct tool is needed for incorporation into busy physician practices. Therefore, a brief HSDD screening tool was developed consisting of four self-report questions with an interpretable cut-score and concise confirmatory physician interview. Main Outcome Measures. Accuracy of the HSDD screener cut-score alone, and in combination with physician interview, was then separately evaluated when compared with in-depth interview diagnosis. Results. The results showed good agreement between the two diagnoses (kappa of 0.669 and 0.562 for cut-score alone and cut-score in combination with physician interview, respectively). Conclusions. The HSDD screener can reliably detect the likely presence of HSDD in postmenopausal women.
引用
收藏
页码:455 / 464
页数:10
相关论文
共 17 条
[1]
Aaronson N, 2002, QUAL LIFE RES, V11, P193
[2]
Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications [J].
Basson, R ;
Berman, J ;
Burnett, A ;
Derogatis, L ;
Ferguson, D ;
Fourcroy, J ;
Goldstein, I ;
Graziottin, A ;
Heiman, J ;
Laan, E ;
Leiblum, S ;
Padma-Nathan, H ;
Rosen, R ;
Segraves, K ;
Segraves, RT ;
Shabsigh, R ;
Sipski, M ;
Wagner, G ;
Whipple, B .
JOURNAL OF UROLOGY, 2000, 163 (03) :888-893
[3]
Summary of the recommendations on sexual dysfunctions in women [J].
Basson, Rosemary ;
Althof, Stan ;
Davis, Susan ;
Fugl-Meyer, Kirsten ;
Goldstein, Irwin ;
Leiblum, Sandra ;
Meston, Cindy ;
Rosen, Raymond ;
Wagner, Gorm .
JOURNAL OF SEXUAL MEDICINE, 2004, 1 (01) :24-34
[4]
Female sexual dysfunction: Incidence, pathophysiology, evaluation, and treatment options [J].
Berman, JR ;
Berman, L ;
Goldstein, I .
UROLOGY, 1999, 54 (03) :385-391
[5]
2X2 KAPPA-COEFFICIENTS - MEASURES OF AGREEMENT OR ASSOCIATION [J].
BLOCH, DA ;
KRAEMER, HC .
BIOMETRICS, 1989, 45 (01) :269-287
[6]
The female sexual distress scale (FSDS): Initial validation of a standardized scale for assessment of sexually related personal distress in women [J].
Derogatis, LR ;
Rosen, R ;
Leiblum, S ;
Burnett, A ;
Heiman, J .
JOURNAL OF SEX & MARITAL THERAPY, 2002, 28 (04) :317-330
[7]
On life satisfaction in male erectile dysfunction [J].
FuglMeyer, AR ;
Lodnert, G ;
Branholm, IB ;
FuglMeyer, KS .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 1997, 9 (03) :141-148
[8]
Harris Interactive, HARR POLL ONL PAN
[9]
MEASUREMENT OF OBSERVER AGREEMENT FOR CATEGORICAL DATA [J].
LANDIS, JR ;
KOCH, GG .
BIOMETRICS, 1977, 33 (01) :159-174
[10]
Sexual dysfunction in the United States - Prevalence and predictors [J].
Laumann, EO ;
Paik, A ;
Rosen, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (06) :537-544